Clinical Trials Directory

Trials / Completed

CompletedNCT04392297

Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals

To Identify the Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals and to Develop Methods for the Diagnosis and Treatment of Patients in This Category

Status
Completed
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
The Republican Research and Practical Center for Epidemiology and Microbiology · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Current study evaluates possible correlations between the content of various cell populations, the genetic material of the virus and antibodies to it in the blood of patients and the risk of thrombosis development in patients with acute CMV infection. А new method for the early detection of immunological and clinical signs of thromboembolic complications of CMV infection in immunocompetent individuals and the treatment of patients in this category will be developed.

Detailed description

* evaluate the immune status main indicators that characterize the activation of immune system, immunosuppression and anergy (myeloid suppressor cells, T-regulatory cells, T-cells according to the stages of differentiation (naive - effector - memory), activated T-cells); * identify and characterize immunological disorders in patients with CMV infection complicated by thromboembolism of various localization; * determine the presence and quantitative content in plasma / serum and neutrophils of the CMV genetic material by real-time PCR; * study humoral immunity to CMV (IgM / IgG antibodies to CMV in serum); * determine the content of CMV specific T-cells in peripheral blood; * develop a method for the early detection of immunological and clinical signs of thromboembolic complications of CMV infection in immunocompetent persons and treatment of patients in this category.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBood leukocyte subsetsDetermination of blood leukocyte subpopulations: myeloid suppressor cells, T-regulatory cells, T-cells according to the stages of differentiation (naive - effector - memory), activated T-cells; circulating endothelial cells
DIAGNOSTIC_TESTCMV specific T-cellsCMV specific T-cells detected by flow cytometry
DIAGNOSTIC_TESTserum CMV IgM / IgG antibodiesserum CMV IgM / IgG antibodies detected by ELISA

Timeline

Start date
2019-07-01
Primary completion
2025-01-31
Completion
2025-01-31
First posted
2020-05-18
Last updated
2025-04-06

Locations

1 site across 1 country: Belarus

Source: ClinicalTrials.gov record NCT04392297. Inclusion in this directory is not an endorsement.